Urothelial carcinomas of the upper urinary tract – how does UK practice compare with European guidelines: is there a difference?

Abstract

Upper urinary tract urothelial carcinomas (UUT-UCs) are relatively rare tumours that present a challenge to urologists, both in terms of diagnosis and treatment. The diagnostic pathway is often complex and the surgical options continue to generate controversy. The outcomes of treatment are mixed, with invasive tumours having a particularly poor prognosis. In this article we compare UK practice with the most recent European Association of Urology (EAU) guidelines for the management of UUT-UCs.

Keywords

Upper urinary tract urothelial carcinoma urological cancer guideline

Get full access to this article

View all access options for this article.

References

NCIN. Bladder cancer incidence, mortality and survival rates in the United Kingdom. London: Public Health England, 2013.

NCIN. Renal pelvis and ureter cancer incidence, mortality and survival rates in the United Kingdom. London: Public Health England, 2013.

Rouprêt

Babjuk

Böhle

et al . Urothelial carcinomas of the upper urinary tract. Arnham: European Association of Urology, 2015.

Babjuk

Oosterlinck

Sylvester

et al . EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update. Eur Urol 2011; 59: 997–1008.

Margulis

Shariat

Matin

et al . Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer 2009; 115: 1224–1233.

Stewart

Bariol

Grigor

et al . A comparison of the pathology of transitional cell carcinoma of the bladder and upper urinary tract. BJU Int 2005; 95: 791–793.

Cosentino

Palou

Gaya

et al . Upper urinary tract urothelial cell carcinoma: location as a predictive factor for concomitant bladder carcinoma. World J Urol 2013; 31: 141–145.

Xylinas

Rink

Margulis

et al . Multifocal carcinoma in situ of the upper tract is associated with high risk of bladder cancer recurrence. Eur Urol 2012; 61: 1069–1070.

Zigeuner

Hutterer

Chromecki

et al . Bladder tumour development after urothelial carcinoma of the upper urinary tract is related to primary tumour location. BJU Int 2006; 98: 1181–1186.

10.

Novara

De Marco

Dalpiaz

et al . Independent predictors of metachronous bladder transitional cell carcinoma (UC) after nephroureterectomy for UC of the upper urinary tract. BJU Int 2008; 101: 1368–1374.

11.

Shen

et al . Oncologic outcomes following three different approaches to the distal ureter and bladder cuff in nephroureterectomy for primary upper urinary tract urothelial carcinoma. Eur Urol 2010; 57: 963–969.

12.

Novara

De Marco

Dalpiaz

et al . Independent predictors of contralateral metachronous upper urinary tract transitional cell carcinoma after nephroureterectomy: multi-institutional dataset from three European centers. Int J Urol 2009; 16: 187–191.

13.

Cowan

. CT urography for hematuria. Nat Rev Urol 2012; 9: 218–226.

14.

Takahashi

Glockner

Hartman

et al . Gadolinium enhanced magnetic resonance urography for upper urinary tract malignancy. J Urol 2010; 183: 1330–1365.

15.

Witjes

Redorta

Jacqmin

et al . Hexaminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: review of the evidence and recommendations. Eur Urol 2010; 57: 607–614.

16.

Messer

Shariat

Brien

et al . Urinary cytology has a poor performance for predicting invasive or high-grade upper-tract urothelial carcinoma. BJU Int 2011; 108: 701–705.

17.

BAUS Complex Operations Data. Final analysis of 2014 data: Nephrectomy. Available at: http://www.baus.org.uk/professionals/baus_business/data_audit.aspx (accessed 7 March 2017).

18.

O’Brien

Ray

Singh

et al . Prevention of bladder tumours after nephroureterectomy for primary upper urinary tract urothelial carcinoma: a prospective, multicentre, randomised clinical trial of a single postoperative intravesical dose of mitomycin C (the ODMIT-C trial). Eur Urol 2011; 60: 703–710.

19.

Hall

Womack

Sagalowsky

et al . Prognostic factors, recurrence and survival in transitional cell carcinoma of the upper urinary tract, a 30-year experience in 252 patients. Urology 1998; 52: 594–601.

20.

Hellenthal

Shariat

Margulis

et al . Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the Upper Tract Urothelial Carcinoma Collaboration. J Urol 2009; 182: 900–906.

21.

Vassilakopoulou

de la Motte Rouge

Colin

et al . Outcomes after adjuvant chemotherapy in the treatment of high-risk urothelial carcinoma of the upper urinary tract (UUT-UC): results from a large multicenter collaborative study. Cancer 2011; 117: 5500–5508.

22.

Leow

Martin-Doyle

Fay

et al . A systematic review and meta-analysis of adjuvant and neoadjuvant chemotherapy for upper tract urothelial carcinoma. Eur Urol 2014; 66: 529–541.

23.

Birtle

Lewis

Johnson

et al . Time to define an international standard of postoperative care for resected upper urinary tract transitional cell carcinoma (UC) - opening of the Peri-Operative Chemotherapy Versus Surveillance in Upper Tract Urothelial Cancer (POUT) Trial. BJU Int 2012; 110: 919–921.

24.

Abouassaly

Alibhai

Shah

et al . Troubling outcomes from population-level analysis of surgery for upper tract urothelial carcinoma. Urology 2010; 76: 895–901.

25.

Jeldres

Sun

Isbarn

et al . A population-based assessment of perioperative mortality after nephroureterectomy for upper-tract urothelial carcinoma. Urology 2010; 75: 315–320.